GO TO CMA Home
GO TO Inside CMA
GO TO Advocacy and Communications
GO TO Member Services
GO TO Publications
GO TO Professional Development
GO TO Clinical Resources

GO TO What's New
GO TO Contact CMA
GO TO Web Site Search
GO TO Web Site Map


CMAJ

July 11, 2000 / le 11 juillet 2000

CMAJ 2000; 163(1)


Highlights of this issue

Cover:
Hyperhomocysteinemia may be linked to the development of coronary artery disease. The Canadian Task Force on Preventive Health Care reviews the evidence of this association and the effect of lowering homocysteine levels through vitamin therapy (page 21 and page 37).

(Photo: Art Explosion; design: Nicole Barbeau)

Hyperhomocysteinemia and coronary artery disease


  Editorial • Éditorial
5 A treatise on water
[HTML / PDF]
7 Un traité sur l'eau
[HTML / PDF]

13 Letters • Correspondance [PDF]
Instructions to correspondents

  Research • Recherche
21 Preventive health care, 2000 update: screening and management of hyperhomocysteinemia for the prevention of coronary artery disease events
G.L. Booth, E.E.L. Wang, with the Canadian Task Force on Preventive Health Care
[HTML / PDF]
  Le point sur les soins de santé préventifs en l'an 2000 : Dépistage et traitement de l'hyperhomocystéinémie pour la prévention des accidents coronariens
G.L. Booth, E.E.L. Wang, et le Groupe d'étude canadien sur les soins de santé préventifs
[HTML / PDF]
31 Changes in the treatment and outcomes of acute myocardial infarction in Quebec, 1988-1995
L. Pilote, F. Lavoie, V. Ho, M.J. Eisenberg
[HTML / PDF]

  Commentary • Commentaire
37 Homocysteine: To screen and treat or to wait and see?
J. Genest Jr., M.-C. Audelin, E. Lonn
[HTML / PDF]
38 Sudden neck movement and cervical artery dissection
J.W. Norris, V. Beletsky, Z.G. Nadareishvili, on behalf of the Canadian Stroke Consortium
[HTML / PDF]
41 Acute myocardial infarction in Canada: improvement with time
A. Dodek
[HTML / PDF]
43 Who wants to pay for health care?
R.B. Deber
[HTML / PDF]

  Review • Synthèse
49 Emerging relations between infectious diseases and coronary artery disease and atherosclerosis
I.W. Fong
[HTML / PDF]
57 Choosing a first-line drug in the management of elevated blood pressure: What is the evidence? 1. Thiazide diuretics
J.M. Wright
[HTML / PDF]
61 Expansion of gambling in Canada: implications for health and social policy
D.A. Korn
[HTML / PDF]

69 The Left Atrium • De l'Oreille Gauche [HTML / PDF]
 
  • Challenges and choices (book review by A. Silversides)
  • What I could not return
  • R is for writing
  • Packaging Picasso

73 News and analysis • Nouvelles et analyses [PDF]
 

143 Deaths • Nécrologie

  Heart & Soul • Gens de cœur
144 "Hey Dad, it's one-armed Will"
S. Wemp
[HTML / PDF]

Health Canada
In this issue of the
Canadian Adverse Drug Reaction Newsletter [PDF]
  • Potentially harmful drug interaction with
    St. John's wort and prescription drugs
  • Olanzapine (Zyprexa®): suspected serious reactions
  • Sildenafil (ViagraTM): cardiac risks
  • New bureau name
  • Communiqué
  • Drugs of Current Interest

eCMAJ articles are available in standard Web format (Hyper Text Markup Language [HTML]) and also in portable document format (PDF). To view and print out the PDF documents, which will resemble the pages of the printed journal, you require Adobe Acrobat Reader (version 3.0 and above). To download this viewer (free), or for assistance with Adobe Acrobat Reader, visit the Adobe Systems Web site: www.adobe.com

© 2000 Canadian Medical Association / Association médicale canadienne



CMAJ Table of Contents by email...subscribe here now!